About HealthSouth Corporation (NYSE:HLS)
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 25 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2016, the Company operated 123 inpatient rehabilitation hospitals. As of December 31, 2016, the Company managed five inpatient rehabilitation units through management contracts.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:HLS
- CUSIP: 42192430
- Web: www.healthsouth.com
- Market Cap: $4.6 billion
- Outstanding Shares: 98,735,000
- 50 Day Moving Avg: $45.36
- 200 Day Moving Avg: $45.47
- 52 Week Range: $36.97 - $49.71
Sales & Book Value:
- Trailing P/E Ratio: 16.98
- Foreward P/E Ratio: 16.17
- P/E Growth: 1.99
- Annual Revenue: $3.77 billion
- Price / Sales: 1.22
- Book Value: $11.18 per share
- Price / Book: 4.17
- Annual Dividend: $1.00
- Dividend Yield: 2.2%
- EBITDA: $817.1 million
- Net Margins: 6.70%
- Return on Equity: 25.07%
- Return on Assets: 5.51%
- Debt-to-Equity Ratio: 1.98%
- Current Ratio: 1.41%
- Quick Ratio: 1.41%
- Average Volume: 779,400 shs.
- Beta: 0.58
- Short Ratio: 5.08
Frequently Asked Questions for HealthSouth Corporation (NYSE:HLS)
What is HealthSouth Corporation's stock symbol?
HealthSouth Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLS."
How often does HealthSouth Corporation pay dividends? What is the dividend yield for HealthSouth Corporation?
HealthSouth Corporation announced a quarterly dividend on Friday, July 21st. Investors of record on Monday, October 2nd will be paid a dividend of $0.25 per share on Monday, October 16th. This represents a $1.00 annualized dividend and a yield of 2.15%. The ex-dividend date is Friday, September 29th. This is an increase from HealthSouth Corporation's previous quarterly dividend of $0.24. View HealthSouth Corporation's Dividend History.
How were HealthSouth Corporation's earnings last quarter?
HealthSouth Corporation (NYSE:HLS) posted its quarterly earnings results on Monday, July, 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. The company earned $981.30 million during the quarter, compared to analysts' expectations of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The business's revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period last year, the business earned $0.69 earnings per share. View HealthSouth Corporation's Earnings History.
When will HealthSouth Corporation make its next earnings announcement?
What guidance has HealthSouth Corporation issued on next quarter's earnings?
HealthSouth Corporation issued an update on its FY17 earnings guidance on Monday, July, 31st. The company provided earnings per share (EPS) guidance of $2.64-2.73 for the period, compared to the Thomson Reuters consensus estimate of $2.69. The company issued revenue guidance of $3.875-3.95 billion, compared to the consensus revenue estimate of $3.94 billion.
Where is HealthSouth Corporation's stock going? Where will HealthSouth Corporation's stock price be in 2017?
8 equities research analysts have issued twelve-month price objectives for HealthSouth Corporation's shares. Their forecasts range from $46.00 to $55.00. On average, they expect HealthSouth Corporation's stock price to reach $50.57 in the next twelve months. View Analyst Ratings for HealthSouth Corporation.
Who are some of HealthSouth Corporation's key competitors?
Some companies that are related to HealthSouth Corporation include NMC Health PLC (NMC), Mednax (MD), Acadia Healthcare Company (ACHC), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO), HealthStream (HSTM), The Providence Service Corporation (PRSC), Community Health Systems (CYH), Kindred Healthcare (KND), Georgia Healthcare Group PLC (GHG), American Renal Associates Holdings (ARA), Cambian Group PLC (CMBN) and Concord Medical Services Holdings Limited (CCM).
Who are HealthSouth Corporation's key executives?
HealthSouth Corporation's management team includes the folowing people:
- Mark J. Tarr, President, Chief Executive Officer
- Douglas E. Coltharp, Chief Financial Officer, Executive Vice President
- April Anthony, Chief Executive Officer and President - Encompass
- Cheryl B. Levy, Chief Human Resource Officer
- Patrick Darby, Executive Vice President, General Counsel, Secretary
- Barbara A. Jacobsmeyer, Executive Vice President - Operations
- Edmund M. Fay, Senior Vice President, Treasurer
- Andrew L. Price CPA, Chief Accounting Officer
- Elissa Joy Charbonneau, Chief Medical Officer
- Leo I. Higdon Jr., Non-Executive Independent Chairman of the Board
Who owns HealthSouth Corporation stock?
HealthSouth Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include APG Asset Management N.V. (0.59%), Mutual of America Capital Management LLC (0.08%), Sit Investment Associates Inc. (0.07%), Shell Asset Management Co. (0.06%), Strs Ohio (0.02%) and Eqis Capital Management Inc. (0.01%). Company insiders that own HealthSouth Corporation stock include Cheryl B Levy, Douglas E Coltharp, Edmund Fay, Joan E Herman, John Chidsey, Leo I Higdon Jr and Mark J Tarr. View Institutional Ownership Trends for HealthSouth Corporation.
Who bought HealthSouth Corporation stock? Who is buying HealthSouth Corporation stock?
HealthSouth Corporation's stock was acquired by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Sit Investment Associates Inc., Shell Asset Management Co., Eqis Capital Management Inc., Mutual of America Capital Management LLC, Foster & Motley Inc., LS Investment Advisors LLC and Strs Ohio. Company insiders that have bought HealthSouth Corporation stock in the last two years include Douglas E Coltharp, Joan E Herman, John Chidsey, Leo I Higdon Jr and Mark J Tarr. View Insider Buying and Selling for HealthSouth Corporation.
How do I buy HealthSouth Corporation stock?
Shares of HealthSouth Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HealthSouth Corporation's stock price today?
MarketBeat Community Rating for HealthSouth Corporation (NYSE HLS)MarketBeat's community ratings are surveys of what our community members think about HealthSouth Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of HealthSouth Corporation stock can currently be purchased for approximately $46.58.
Consensus Ratings for HealthSouth Corporation (NYSE:HLS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 3 Hold Ratings, 4 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.38)|
|Consensus Price Target: ||$50.57 (8.57% upside)|Consensus Price Target History for HealthSouth Corporation (NYSE:HLS)
Analysts' Ratings History for HealthSouth Corporation (NYSE:HLS)
(Data available from 10/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/9/2017||Robert W. Baird||Reiterated Rating||Buy||$55.00||N/A|
|9/17/2017||Piper Jaffray Companies||Reiterated Rating||Hold||$50.00||High|
|9/6/2017||Royal Bank Of Canada||Reiterated Rating||Buy||$55.00||Medium|
|7/10/2017||Mizuho||Boost Price Target||Neutral -> Neutral||$44.00 -> $47.00||Medium|
|5/1/2017||Barclays PLC||Reiterated Rating||Underweight||$44.00 -> $46.00||Low|
|2/13/2017||Craig Hallum||Initiated Coverage||Buy||$48.00||N/A|
|9/11/2016||Wells Fargo & Company||Reiterated Rating||Buy||N/A|
|9/4/2016||JMP Securities||Reiterated Rating||Buy||N/A|
|8/1/2016||SunTrust Banks, Inc.||Set Price Target||Buy||$54.00||N/A|
|2/25/2016||Susquehanna Bancshares Inc||Lower Price Target||Positive||$50.00 -> $42.00||N/A|
|11/6/2015||Wedbush||Lower Price Target||Neutral||$51.00 -> $45.00||N/A|
|10/30/2015||Raymond James Financial, Inc.||Reiterated Rating||Outperform||$51.00 -> $42.00||N/A|
|10/29/2015||Stifel Nicolaus||Downgrade||Buy -> Hold||$52.00||N/A|
Earnings History for HealthSouth Corporation (NYSE:HLS)Earnings History by Quarter for HealthSouth Corporation (NYSE HLS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/31/2017||Q2 2017||$0.68||$0.71||$976.46 million||$981.30 million||View||N/A|
|4/27/2017||Q1 2017||$0.65||$0.70||$960.05 million||$974.80 million||View||N/A|
|2/21/2017||Q416||$0.62||$0.72||$951.18 million||$949.90 million||View||N/A|
|10/27/2016||Q316||$0.60||$0.65||$448.60 million||$926.80 million||View||N/A|
|7/28/2016||Q2||$0.60||$0.69||$906.67 million||$920.70 million||View||N/A|
|4/26/2016||Q116||$0.55||$0.61||$892.87 million||$909.80 million||View||N/A|
|2/23/2016||Q415||$0.59||$0.59||$859.48 million||$879.30 million||View||Listen|
|10/28/2015||Q315||$0.59||$0.52||$756.85 million||$778.60 million||View||Listen|
|7/29/2015||Q215||$0.58||$0.47||$746.86 million||$764.40 million||View||Listen|
|4/30/2015||Q115||$0.56||$0.44||$731.30 million||$740.60 million||View||N/A|
|2/24/2015||Q414||$0.52||$0.55||$609.40 million||$613.40 million||View||N/A|
|10/27/2014||Q314||$0.48||$0.53||$595.30 million||$597.00 million||View||N/A|
|7/28/2014||Q214||$0.47||$0.54||$588.94 million||$604.40 million||View||N/A|
|4/28/2014||Q114||$0.49||$0.48||$594.07 million||$591.20 million||View||N/A|
|2/19/2014||Q413||$0.43||$0.52||$575.55 million||$572.10 million||View||N/A|
|10/29/2013||Q313||$0.41||$0.59||$557.50 million||$564.00 million||View||N/A|
|7/25/2013||Q2 2013||$0.42||$0.51||$553.63 million||$564.50 million||View||N/A|
|4/25/2013||Q1 2013||$0.42||$0.48||$563.86 million||$572.60 million||View||N/A|
Earnings Estimates for HealthSouth Corporation (NYSE:HLS)
2017 EPS Consensus Estimate: $2.68
2018 EPS Consensus Estimate: $2.94
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for HealthSouth Corporation (NYSE:HLS)
|Most Recent Dividend:||10/16/2017|
|Dividend Growth:||72.90% (3 Year Average)|
|Payout Ratio:||36.76% (Trailing 12 Months of Earnings) |
36.90% (Based on This Year's Estimates)
34.72% (Based on Next Year's Estimates)
|Track Record:||3 Years of Consecutive Dividend Growth|
Dividend History by Quarter for HealthSouth Corporation (NYSE HLS)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for HealthSouth Corporation (NYSE:HLS)
Insider Ownership Percentage: 1.60%Insider Trades by Quarter for HealthSouth Corporation (NYSE:HLS)
Institutional Ownership Percentage: 93.08%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/7/2017||Mark J Tarr||CEO||Sell||22,625||$43.00||$972,875.00|| |
|8/3/2017||Mark J Tarr||CEO||Sell||22,625||$42.55||$962,693.75|| |
|11/9/2016||Douglas E Coltharp||CFO||Buy||6,450||$39.14||$252,453.00|| |
|11/9/2016||Mark J Tarr||COO||Buy||6,371||$39.29||$250,316.59|| |
|8/2/2016||Mark J Tarr||COO||Sell||20,000||$41.85||$837,000.00|| |
|4/29/2016||Cheryl B Levy||Insider||Sell||11,000||$41.44||$455,840.00|| |
|3/1/2016||Edmund Fay||Treasurer||Sell||16,240||$35.50||$576,520.00|| |
|1/11/2016||John Chidsey||Director||Buy||799||$35.78||$28,588.22|| |
|11/5/2015||Joan E Herman||Director||Buy||1,000||$35.28||$35,280.00|| |
|11/2/2015||Leo I Higdon Jr||Director||Buy||1,000||$34.81||$34,810.00|| |
|2/27/2015||Andrew L Price||CAO||Sell||1,145||$43.84||$50,196.80|| |
|2/27/2015||Mark J Tarr||COO||Sell||11,000||$43.82||$482,020.00|| |
|5/9/2014||Jay Grinney||CEO||Sell||38,000||$33.42||$1,269,960.00|| |
|5/6/2014||Jay Grinney||CEO||Sell||50,000||$34.51||$1,725,500.00|| |
|3/7/2014||Jay Grinney||CEO||Sell||89,000||$32.57||$2,898,730.00|| |
|11/14/2013||Mark Tarr||COO||Sell||11,000||$35.27||$387,970.00|| |
|5/6/2013||Leslye G Katz||Director||Buy||1,000||$28.40||$28,400.00|| |
|11/7/2012||Jay Grinney||CEO||Buy||11,300||$21.95||$248,035.00|| |
Headline Trends for HealthSouth Corporation (NYSE:HLS)
Latest Headlines for HealthSouth Corporation (NYSE:HLS)
Loading headlines, please wait.
HealthSouth Corporation (HLS) Chart for Monday, October, 23, 2017